E Wesley Ely News Today

A new statement on end-of-life care threatens established Catholic tradition.

Clinical leaders from Penn Medicine and Vanderbilt University Medical Center are among the awardees of the American Association of Critical-Care Nurses 2023 leadership awards.

The same controversial sedatives used on death row inmates during the execution process have recently come under greater ...

Young people turn to TikTok to fight back against rapidly emerging stereotypes about monkeypox, display what their symptoms look like, and urge others to pay attention and get vaccinated.

Reduction in death seen at 28, 60 days for patients receiving invasive mechanical ventilation, extracorporeal membrane oxygenation.

For critically ill hospitalized patients with COVID-19 receiving invasive mechanical ventilation or extracorporeal membrane oxygenation, baricitinib plus standard of care is associated with reduced mortality.

The pro-euthanasia case is promoted and buttressed by stories of ‘bad’ natural deaths, those where great suffering is experienced, and ‘good’ euthanasia deaths, those were suffering is promptly and completely eradicated through the intentional extinguishing of life, itself, by using euthanasia. The case against euthanasia is much more difficult to promote, not because it is weak — it is not — but because it is much more complex. By Margaret Somerville

Coronavirus patients who require treatment in an intensive care unit could suffer from post-intensive care syndrome (PICS), experts say. In general, patients who require intensive care are at risk for mental health issues such as post-traumatic stress disorder, anxiety and depression when their treatment is over, according to Weill Cornell Medicine at Cornell University. They also can suffer ...

Search jobs 09-Apr-2021 Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patients - Randomized, double-blind, placebo-controlled study of 1,525 patients did not meet statistical significance on primary endpoint (progression to non-invasive ventilation or invasive mechanical ventilation or death) - Data showed 38% reduction in mortality by Day 28 (nominal p-value=0.0018) in patients treated w...

(0) INDIANAPOLIS (dpa-AFX) - Eli Lilly and Company (LLY) and Incyte (INCY) on Thursday said their late-stage study of baricitinib in hospitalized Covid-19 patients did not achieve the main goal. The phase III study dubbed Cov-Barrier of baricitinib plus standard of care (SoC) versus placebo plus SoC did not meet statistical significance on the primary endpoint. The main goal was defined as the difference in the proportion of participants progressing to the first occurrence of non-invasive venti...